Adaptive Biotechnologies CCO Susan Bobulsky sells 1,195 shares
Susan Bobulsky, Adaptive Biotechnologies’ Chief Commercial Officer, sold 1,195 common shares on Sep. 15 at $27 per share.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.